Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

AcelRx Pharmaceuticals, Inc. (ACRX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Visitors trend2W10W9M
0.5800-0.0090 (-1.53%)
At close: 04:00PM EDT
Advertisement
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2023)Next Qtr. (Dec 2023)Current Year (2023)Next Year (2024)
No. of Analysts1111
Avg. Estimate-0.29-0.21-1.43-0.75
Low Estimate-0.29-0.21-1.43-0.75
High Estimate-0.29-0.21-1.43-0.75
Year Ago EPS-0.94-15.72-1.43
Revenue EstimateCurrent Qtr. (Sep 2023)Next Qtr. (Dec 2023)Current Year (2023)Next Year (2024)
No. of Analysts1111
Avg. EstimateN/AN/A250kN/A
Low EstimateN/AN/A250kN/A
High EstimateN/AN/A250kN/A
Year Ago Sales507k252k1.77M250k
Sales Growth (year/est)N/AN/A-85.90%N/A
Earnings History9/29/202212/30/20223/30/20236/29/2023
EPS Est.-1.2-0.51-1.39-0.53
EPS Actual-0.94-1-0.75-0.4
Difference0.26-0.490.640.13
Surprise %21.70%-96.10%46.00%24.50%
EPS TrendCurrent Qtr. (Sep 2023)Next Qtr. (Dec 2023)Current Year (2023)Next Year (2024)
Current Estimate-0.29-0.21-1.43-0.75
7 Days Ago-0.29-0.21-1.43-0.69
30 Days Ago-0.29-0.21-1.43-0.69
60 Days Ago-0.5-0.48-2.26-2
90 Days Ago-0.47-0.63-2.04-1.65
EPS RevisionsCurrent Qtr. (Sep 2023)Next Qtr. (Dec 2023)Current Year (2023)Next Year (2024)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/A1
Growth EstimatesACRXIndustrySector(s)S&P 500
Current Qtr.69.10%N/AN/AN/A
Next Qtr.79.00%N/AN/AN/A
Current Year-125.00%N/AN/AN/A
Next Year47.60%N/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A
Advertisement
Advertisement